Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuraminidase (NA) is a major surface glycoprotein found on influenza A viruses, including the H5N1 subtype. It functions as a sialidase, cleaving terminal sialic acid residues to facilitate the release of progeny virions from infected host cells. NA is essential for efficient viral spread and is a key target for antiviral drugs like oseltamivir and zanamivir. However, mutations in the NA gene can lead to drug resistance and antigenic drift, posing challenges for treatment and vaccine development.
Neuraminidase inhibition
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuraminidase protein (NA).